Related Experiment Video
Updated: Jun 29, 2025
06:34
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
219
Galactose: A Versatile Vector Unveiling the Potentials in Drug Delivery, Diagnostics, and Theranostics
Chiara Battisegola1, Chiara Billi1, Maria Cristina Molaro1
1Department of Pharmacy, "Federico II" University of Naples, 80131 Naples, Italy.
Pharmaceuticals (Basel, Switzerland)
|March 28, 2024
Summary
D-galactose serves as a versatile scaffold for targeted drug delivery and diagnostics. This review updates on its use in prodrug design, enhancing cellular uptake and liver function assessment.
Area of Science:
- Biochemistry
- Pharmacology
- Biotechnology
Background:
- D-galactose is a natural monosaccharide with unique properties.
- It interacts with specific cell receptors, enabling targeted applications.
- Galactose has potential in drug delivery, diagnostics, and theranostics.
Purpose of the Study:
- To provide an updated review on D-galactose as a vector.
- To highlight its applications in prodrug design, diagnostics, and theranostics.
- To discuss synthetic strategies for galactose-based agents.
Main Methods:
- Literature review of D-galactose applications.
- Analysis of galactose's role as a targeting ligand.
- Examination of diagnostic tests utilizing galactose.
- Review of theranostic agent design.
Main Results:
- D-galactose enhances cellular uptake of drugs when conjugated to them or drug carriers.
- It targets specific cells like hepatocytes, macrophages, and cancer cells.
- Galactose-based tests, such as galactose elimination capacity, assess liver function.
- Theranostic agents combining drug delivery and diagnostics are feasible.
Conclusions:
- D-galactose is a highly versatile vector for advanced biomedical applications.
- Its ability to target specific cells and aid in diagnostics is crucial.
- Further research into synthetic strategies will expand its utility.
Related Concept Videos
01:32Secondary Active Transport
7.0K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.0K
01:27Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K